These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7530827)

  • 21. Complementary DNA cloning and characterization of truncated form of c-kit in human colon carcinoma cells.
    Toyota M; Hinoda Y; Itoh F; Takaoka A; Imai K; Yachi A
    Cancer Res; 1994 Jan; 54(1):272-5. PubMed ID: 7505199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12.
    Spritz RA; Strunk KM; Lee ST; Lu-Kuo JM; Ward DC; Le Paslier D; Altherr MR; Dorman TE; Moir DT
    Genomics; 1994 Jul; 22(2):431-6. PubMed ID: 7528718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidylinositol 3'-kinase associates with p145c-kit as part of a cell type characteristic multimeric signalling complex.
    Shearman MS; Herbst R; Schlessinger J; Ullrich A
    EMBO J; 1993 Oct; 12(10):3817-26. PubMed ID: 7691598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation of signal transfer complexes between stem cell and platelet-derived growth factor receptors and SH2 domain proteins in vitro.
    Herbst R; Shearman MS; Jallal B; Schlessinger J; Ullrich A
    Biochemistry; 1995 May; 34(17):5971-9. PubMed ID: 7537096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the major phosphorylation sites for protein kinase C in kit/stem cell factor receptor in vitro and in intact cells.
    Blume-Jensen P; Wernstedt C; Heldin CH; Rönnstrand L
    J Biol Chem; 1995 Jun; 270(23):14192-200. PubMed ID: 7539802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
    Yarden Y; Kuang WJ; Yang-Feng T; Coussens L; Munemitsu S; Dull TJ; Chen E; Schlessinger J; Francke U; Ullrich A
    EMBO J; 1987 Nov; 6(11):3341-51. PubMed ID: 2448137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of W mutations on p145c-kit tyrosine kinase activity and substrate interaction.
    Herbst R; Shearman MS; Obermeier A; Schlessinger J; Ullrich A
    J Biol Chem; 1992 Jul; 267(19):13210-6. PubMed ID: 1377679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation.
    Tsujimura T; Furitsu T; Morimoto M; Isozaki K; Nomura S; Matsuzawa Y; Kitamura Y; Kanakura Y
    Blood; 1994 May; 83(9):2619-26. PubMed ID: 7513208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570.
    Chaix A; Arcangeli ML; Lopez S; Voisset E; Yang Y; Vita M; Letard S; Audebert S; Finetti P; Birnbaum D; Bertucci F; Aurrand-Lions M; Dubreuil P; De Sepulveda P
    Oncogene; 2014 Feb; 33(7):872-81. PubMed ID: 23416972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of down-regulation of c-kit receptor. Roles of receptor tyrosine kinase, phosphatidylinositol 3'-kinase, and protein kinase C.
    Yee NS; Hsiau CW; Serve H; Vosseller K; Besmer P
    J Biol Chem; 1994 Dec; 269(50):31991-8. PubMed ID: 7527401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of oncogene study].
    Toyoshima K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):497-503. PubMed ID: 6309088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of Ros differentially effecting signal transduction pathways leading to cell growth versus transformation.
    Zong CS; Chan JL; Yang SK; Wang LH
    J Biol Chem; 1997 Jan; 272(3):1500-6. PubMed ID: 8999820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Replacement" of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential.
    Browning PJ; Bunn HF; Cline A; Shuman M; Nienhuis AW
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7800-4. PubMed ID: 3532121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions.
    Liu D; Zong CS; Wang LH
    J Virol; 1993 Nov; 67(11):6835-40. PubMed ID: 7692086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The organization of c-rel in chicken and turkey DNAS.
    Wilhelmsen KC; Chen IS; Temin HM
    Prog Clin Biol Res; 1983; 119():43-56. PubMed ID: 6306690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The kinase activity of the v-fms encoded protein has a low pH optimum.
    Lyman SD; Rohrschneider LR
    Oncogene Res; 1989; 4(2):149-55. PubMed ID: 2654815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and biochemical bases for activation of the transforming potential of the proto-oncogene c-ros.
    Zong CS; Poon B; Chen J; Wang LH
    J Virol; 1993 Nov; 67(11):6453-62. PubMed ID: 8411348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence of a bovine c-kit proto-oncogene cDNA.
    Kubota T; Hikono H; Sasaki E; Sakurai M
    Gene; 1994 Apr; 141(2):305-6. PubMed ID: 7512939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substrate phosphorylation specificity of the human c-kit receptor tyrosine kinase.
    Herbst R; Lammers R; Schlessinger J; Ullrich A
    J Biol Chem; 1991 Oct; 266(30):19908-16. PubMed ID: 1718957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular evolution of the genes encoding receptor tyrosine kinase with immunoglobulinlike domains.
    Rousset D; Agnès F; Lachaume P; André C; Galibert F
    J Mol Evol; 1995 Oct; 41(4):421-9. PubMed ID: 7563129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.